Dr. Morena D’Alise (VP of Immunology) is presenting at the SITC Annual Meeting 2023, San Diego November 1-3

 In Presentations

PRESENTATION TITLE: Late-Breaking Oral Abstract Presentation: NOUS-209 genetic vaccine encoding shared cancer neoantigens is safe and elicits robust immune response in healthy Lynch syndrome carriers: interim results from Phase 1 cancer interception trial

Read more
Recent Posts
error: Content is protected !!!
Dr. Elisa Scarselli (Nouscom CSO) invited speaker at EHTG European Hereditary Tumour Group 2023, Vilnius September 28 – October 1stPresentations